Aifa has created a task force to quickly respond to the approximately 31,000 non-conventional medicinal products (those commonly defined as homeopathic or natural) awaiting authorisation. Objective: bring the sector into line with the rest of Europe in the next two-three years and in any case by 2015. This was explained by the former general manager of the Italian drug agency, Guido Rasi, now executive director of the EMA in his speech at the conference Non-conventional medicines, do we need a regulation? organized in the Senate by the parliamentary association for the protection and promotion of the right to prevention. Underlining the need to rigorously regulate the sector, Rasi clarified that the work "began some time ago but up to now only one expert from the agency has dealt with non-conventional products", leading to the evaluation of about 400 products, while in the coming months there will be a group, thanks to the 200 new hires at AIFA, which will dedicate itself to non-conventional medicine to evaluate all products by 2015 when the transitional regime provided for by the European Directive on the registration of homeopathic medicines will end ethical and anthroposophic.
DoctorNews – October 12, 2011
